vs
Side-by-side financial comparison of First Foundation Inc. (FFWM) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $48.4M, roughly 1.6× First Foundation Inc.). On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-35.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -2.7%).
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FFWM vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $75.5M |
| Net Profit | $-8.0M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -97.5% | 22.7% |
| Net Margin | -97.9% | — |
| Revenue YoY | 421.7% | 27.7% |
| Net Profit YoY | 43.0% | — |
| EPS (diluted) | $-0.09 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $75.5M | ||
| Q3 25 | $63.6M | $54.5M | ||
| Q2 25 | $51.4M | $52.4M | ||
| Q1 25 | $71.4M | $46.0M | ||
| Q4 24 | $9.3M | $59.1M | ||
| Q3 24 | $9.2M | $80.5M | ||
| Q2 24 | $57.5M | $47.1M | ||
| Q1 24 | $51.1M | $43.8M |
| Q4 25 | $-8.0M | — | ||
| Q3 25 | $-146.3M | $8.8M | ||
| Q2 25 | $-7.7M | $5.9M | ||
| Q1 25 | $6.9M | $3.0M | ||
| Q4 24 | $-14.1M | — | ||
| Q3 24 | $-82.2M | $20.3M | ||
| Q2 24 | $3.1M | $-4.5M | ||
| Q1 24 | $793.0K | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -97.5% | 22.7% | ||
| Q3 25 | -92.7% | 17.6% | ||
| Q2 25 | -21.1% | 12.7% | ||
| Q1 25 | 8.8% | 8.7% | ||
| Q4 24 | -247.7% | 22.6% | ||
| Q3 24 | -1276.7% | 27.4% | ||
| Q2 24 | 4.6% | -4.6% | ||
| Q1 24 | -0.2% | -5.3% |
| Q4 25 | -97.9% | — | ||
| Q3 25 | -230.1% | 16.2% | ||
| Q2 25 | -15.0% | 11.2% | ||
| Q1 25 | 9.7% | 6.5% | ||
| Q4 24 | -152.2% | — | ||
| Q3 24 | -896.9% | 25.2% | ||
| Q2 24 | 5.4% | -9.6% | ||
| Q1 24 | 1.6% | -11.0% |
| Q4 25 | $-0.09 | $0.26 | ||
| Q3 25 | $-1.78 | $0.17 | ||
| Q2 25 | $-0.09 | $0.12 | ||
| Q1 25 | $0.08 | $0.06 | ||
| Q4 24 | $-0.24 | $0.40 | ||
| Q3 24 | $-1.23 | $0.41 | ||
| Q2 24 | $0.05 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.6B | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $912.6M | $130.3M |
| Total Assets | $11.9B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.6B | $97.5M | ||
| Q3 25 | $1.7B | $94.4M | ||
| Q2 25 | $1.1B | $96.0M | ||
| Q1 25 | $1.0B | $93.2M | ||
| Q4 24 | $1.0B | $101.0M | ||
| Q3 24 | $1.1B | $96.7M | ||
| Q2 24 | $1.4B | $96.8M | ||
| Q1 24 | $1.6B | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $912.6M | $130.3M | ||
| Q3 25 | $917.9M | $115.3M | ||
| Q2 25 | $1.1B | $104.7M | ||
| Q1 25 | $1.1B | $97.1M | ||
| Q4 24 | $1.1B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $933.2M | $48.5M | ||
| Q1 24 | $928.7M | $51.0M |
| Q4 25 | $11.9B | $216.3M | ||
| Q3 25 | $11.9B | $202.9M | ||
| Q2 25 | $11.6B | $194.9M | ||
| Q1 25 | $12.6B | $196.2M | ||
| Q4 24 | $12.6B | $213.3M | ||
| Q3 24 | $13.4B | $220.7M | ||
| Q2 24 | $13.7B | $205.0M | ||
| Q1 24 | $13.6B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.9M | $14.4M |
| Free Cash FlowOCF − Capex | $-35.2M | $14.4M |
| FCF MarginFCF / Revenue | -72.8% | 19.1% |
| Capex IntensityCapex / Revenue | 6.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.9M | $14.4M | ||
| Q3 25 | $9.2M | $9.7M | ||
| Q2 25 | $-16.3M | $14.1M | ||
| Q1 25 | $-552.0K | $3.6M | ||
| Q4 24 | $-8.7M | $15.6M | ||
| Q3 24 | $14.2M | $11.0M | ||
| Q2 24 | $-9.1M | $1.0M | ||
| Q1 24 | $7.2M | $11.2M |
| Q4 25 | $-35.2M | $14.4M | ||
| Q3 25 | $8.6M | $9.7M | ||
| Q2 25 | $-16.7M | $14.1M | ||
| Q1 25 | $-2.5M | $3.6M | ||
| Q4 24 | $-11.4M | $15.6M | ||
| Q3 24 | $13.4M | $11.0M | ||
| Q2 24 | $-9.4M | $1.0M | ||
| Q1 24 | $5.9M | — |
| Q4 25 | -72.8% | 19.1% | ||
| Q3 25 | 13.5% | 17.7% | ||
| Q2 25 | -32.4% | 26.8% | ||
| Q1 25 | -3.5% | 7.7% | ||
| Q4 24 | -123.5% | 26.4% | ||
| Q3 24 | 146.2% | 13.7% | ||
| Q2 24 | -16.3% | 2.1% | ||
| Q1 24 | 11.6% | — |
| Q4 25 | 6.9% | 0.0% | ||
| Q3 25 | 1.0% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 29.4% | 0.0% | ||
| Q3 24 | 9.0% | 0.0% | ||
| Q2 24 | 0.4% | 0.0% | ||
| Q1 24 | 2.5% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | -0.08× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -2.96× | — | ||
| Q1 24 | 9.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
